Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Leelamine
1. 1446-61-3
2. (+)-dehydroabietylamine
3. Leelamine
4. Dehydroabiethylamine
5. ((1r,4as,10ar)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)methanamine
6. Amine D
7. Chembl70488
8. Nsc-2955
9. 33289o147p
10. 1-phenanthrenemethanamine, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1r,4as,10ar)-
11. Caswell No. 276
12. Podocarpa-8,11,13-trien-15-amine, 13-isopropyl-
13. Lylamine
14. Hsdb 5665
15. Unii-33289o147p
16. Einecs 215-899-7
17. Epa Pesticide Chemical Code 004206
18. Brn 3084620
19. 13-isopropylpodocarpa-8,11,13-trien-15-amine
20. Schembl27863
21. Dehydroabietylamine (>80%)
22. 4-12-00-03005 (beilstein Handbook Reference)
23. Mls002207102
24. Dtxsid2041834
25. Chebi:93086
26. Dehydroabietylamine [hsdb]
27. Nsc2955
28. (+)-dehydroabietylamine; >95%
29. Nsc 2955
30. Zinc3860856
31. Bdbm50217007
32. Akos015914070
33. Cs-w005629
34. Hy-w005629
35. 1-phenanthrenemethanamine, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1r-(1alpha,4abeta,10aalpha))-
36. Ds-18554
37. Smr001306713
38. D1180
39. D1588
40. (+)-dehydroabietylamine, Technical Grade, 60%
41. Podocarpa-8,13-trien-15-amine, 13-isopropyl-
42. A884771
43. W-108153
44. Brd-k62289640-003-01-9
45. Q15409408
46. 1-phenanthrenemethanamine 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-,(1r,4as,10ar)-
47. 1-phenanthrenemethanamine,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, [1r-(1.alpha.,4a.beta.,10a.alpha.)]-
| Molecular Weight | 285.5 g/mol |
|---|---|
| Molecular Formula | C20H31N |
| XLogP3 | 5.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 2 |
| Exact Mass | 285.245649993 g/mol |
| Monoisotopic Mass | 285.245649993 g/mol |
| Topological Polar Surface Area | 26 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 376 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
54
PharmaCompass offers a list of Dehydroabietylamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dehydroabietylamine manufacturer or Dehydroabietylamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dehydroabietylamine manufacturer or Dehydroabietylamine supplier.
PharmaCompass also assists you with knowing the Dehydroabietylamine API Price utilized in the formulation of products. Dehydroabietylamine API Price is not always fixed or binding as the Dehydroabietylamine Price is obtained through a variety of data sources. The Dehydroabietylamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dehydroabietylamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dehydroabietylamine, including repackagers and relabelers. The FDA regulates Dehydroabietylamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dehydroabietylamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dehydroabietylamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dehydroabietylamine supplier is an individual or a company that provides Dehydroabietylamine active pharmaceutical ingredient (API) or Dehydroabietylamine finished formulations upon request. The Dehydroabietylamine suppliers may include Dehydroabietylamine API manufacturers, exporters, distributors and traders.
click here to find a list of Dehydroabietylamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Dehydroabietylamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dehydroabietylamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dehydroabietylamine GMP manufacturer or Dehydroabietylamine GMP API supplier for your needs.
A Dehydroabietylamine CoA (Certificate of Analysis) is a formal document that attests to Dehydroabietylamine's compliance with Dehydroabietylamine specifications and serves as a tool for batch-level quality control.
Dehydroabietylamine CoA mostly includes findings from lab analyses of a specific batch. For each Dehydroabietylamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dehydroabietylamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Dehydroabietylamine EP), Dehydroabietylamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dehydroabietylamine USP).
